Colon Cancer ICD-10 Codes: Complete Guide to Accurate Diagnosis Coding
November 13, 2026
November 13, 2026

Colon cancer claims can be rendered inaccurate prior to submission to the payer because a physician may indicate sigmoid colon cancer on the claim but the coding department picks a code for unspecified malignant neoplasm. On another claim, the claimant may have active cancer despite having received treatment many months ago.
ICD-10 codes for colon cancer include codes that belong to category C18, which is associated with malignant neoplasms according to their anatomical site. Code C18.9 is malignant neoplasm of the colon, unspecified, whereas codes for individual sites in the colon are provided.
It is also important for healthcare practitioners and coders to understand how active cancer, metastatic, carcinoma in situ, and personal history differ from each other.
The ICD-10-CM coding system codes malignant neoplasms of the colon using the code C18. The actual code depends on the location of the tumor.
For instance, C18.2 is the code for ascending colon cancer, while C18.7 is for sigmoid colon cancer, and C18.9 if the location is unspecified.
The CDC’s ICD-10-CM classification provides the official code set, while the CMS coding guidelines explain diagnosis reporting and sequencing requirements.
The following table includes the active malignant neoplasm codes in category C18 for FY 2027, effective October 1, 2026, through September 30, 2027.
| ICD-10-CM Code | Official Diagnosis Description |
| C18.0 | Malignant neoplasm of cecum |
| C18.1 | Malignant neoplasm of appendix |
| C18.2 | Malignant neoplasm of ascending colon |
| C18.3 | Malignant neoplasm of hepatic flexure |
| C18.4 | Malignant neoplasm of transverse colon |
| C18.5 | Malignant neoplasm of splenic flexure |
| C18.6 | Malignant neoplasm of descending colon |
| C18.7 | Malignant neoplasm of sigmoid colon |
| C18.8 | Malignant neoplasm of overlapping sites of colon |
| C18.9 | Malignant neoplasm of colon, unspecified |
Source: CDC FY 2027 ICD-10-CM Tabular List. Although the classification includes appendix cancer under C18.1, providers should not treat every appendix malignancy as conventional colon adenocarcinoma.
ftp.cdc.gov
Use of C18.9 should occur if there is documentation of colon cancer, but the body part is not specified.
For instance, a patient might have the following diagnosis on the chart: “Malignant neoplasm of colon.” The patient could be coded with C18.9. However, if the pathology report, operative findings, or physician’s documentation point to a specific location, it is best for the coder to determine that first.
These codes represent varying scenarios.
It is important to note that not every tumor that involves two contiguous colon segments qualifies for the use of code C18.8.
Providers frequently use “colorectal cancer” as a broad clinical term. ICD-10-CM, however, distinguishes colon, rectosigmoid junction, and rectal malignancies.
| Cancer Location | ICD-10-CM Code |
| Colon | C18.0–C18.9 |
| Rectosigmoid junction | C19 |
| Rectum | C20 |
For instance, when the cancer is derived from the sigmoid colon, it can be coded as C18.7. However, cancer that arises from the rectosigmoid junction will have to be coded under C19.
It is important for coders to look into the description provided by the doctor before coding either of these diagnoses.
A previous colon cancer diagnosis does not automatically justify an active malignancy code.
Under the FY 2027 ICD-10-CM Official Guidelines, Coders should keep coding an active primary malignancy even if the patient is being treated for the same site.
After the patient undergoes treatment and the provider no longer detects any evidence of primary malignancy at that particular site, then a personal history code can be used.
| Clinical Situation | Coding Consideration |
| Active sigmoid colon malignancy | C18.7 |
| Active colon malignancy without specified site | C18.9 |
| Previous colon malignancy, eradicated, no further treatment | Z85.038 |
| Follow-up examination after completed cancer treatment | Z08, with applicable history code |
Z85.038 refers to personal history of other malignant neoplasms of the colon, which includes past history of primary malignancy, classified as C18.
Encounters subsequent to completion of cancer management procedures should consult coding guidelines for Z08 and appropriate history code.
Colon cancer can metastasize into liver, lungs, lymph nodes, and elsewhere. Billing personnel should be able to differentiate between the primary cancer and its secondary sites where providers have identified metastases.
Secondary malignancy codes are as follows:
Code selection should be based on the presence of the following conditions in the patient: active primary colon cancer, a cured primary cancer, or something else.
Patient treatment is targeted towards an actively progressing primary ascending colon cancer with a confirmed metastatic spread to the liver.
Coding can be done as follows:
It depends on the treatment intent for the encounter as to whether the primary or the secondary cancer is coded first.
The CMS neoplasm sequencing guidelines explain these distinctions.
Centers for Medicare & Medicaid Services
Pathology report indicating carcinoma in situ cannot be used to prove colon cancer is invasive.
The following classification is used:
Coding of high grade dysplasia, a benign adenoma or unconfirmed diagnosis cannot be interpreted as invasive colon cancer.
It is important to differentiate between these classifications when coding colonoscopy, polypectomy, pathology and oncology services.
Diagnosis code alone is insufficient to make an oncology claim fully completed. The biller should sequence the diagnoses based on the purpose of the visit.
For the situation where the patient is coming to be seen mainly to receive antineoplastic chemotherapy, it is advised that the appropriate codes for such encounters should come first and they include:
Also included is the diagnosis code for the malignant condition.
Billers should be able to tell the difference between colonoscopy screening and diagnosis.
In case where the patient visits the hospital for colorectal cancer screening but is asymptomatic or does not have cancer at that particular time, this is not the same situation as when the patient is visiting the hospital for colonoscopy as a result of bleeding or tumor.
The coders should always be aware of the purpose of the procedure, the findings, and the payer guidelines. C18.9 should never be coded just because the physician ordered for colonoscopy.
| Coding Error | Recommended Action |
| Using C18.9 despite documented location | Select the supported anatomical code |
| Reporting active cancer after completed treatment | Review personal history criteria |
| Confusing sigmoid cancer with rectosigmoid cancer | Confirm the primary tumor site |
| Using primary liver cancer codes for metastases | Identify the documented secondary malignancy |
| Coding suspected cancer as confirmed in outpatient care | Follow outpatient uncertain-diagnosis rules |
| Sequencing active cancer first for every chemotherapy encounter | Review treatment encounter guidelines |
These errors can create diagnosis-to-service mismatches, prompt documentation requests, or contribute to denials under applicable payer policies.
Five major reviews may help providers and billers to make claims of high quality.
The medical billing process ensures proper coordination of documentation review, correction of codes and claims follow up without returning claims back to clinical staff.
C18.9 identifies malignant neoplasm of the colon, unspecified. More specific codes from the C18 category should be used when documentation supports a specific site.
C18.7 identifies malignant neoplasm of the sigmoid colon. Care must be taken not to confuse this condition with rectosigmoid junction cancer, coded C19.
Z85.038 identifies personal history of other malignant neoplasms of the large intestine. This code depends on whether there has been completed therapy and no current primary malignancy in that area.
Most guidelines for outpatient coding discourage coders from coding uncertain diagnoses as confirmed malignancies. Coders should use documented symptoms, findings, or any other reason for the visit until the physician makes an actual diagnosis.
Yes. The ICD-10-CM separates colon cancer under C18, rectosigmoid junction cancer under C19, and rectal cancer under C20.
Code C18.9 refers to the anatomical diagnosis but does not provide information regarding the section of the colon involved. No stage of TNM is indicated.
Correct colon cancer ICD-10 coding starts with the location of the tumor; however, one must take into consideration the following information: treatment, metastasis, and the reason for visit.
When practitioners provide clear information on these factors, coders have an easier job when choosing diagnosis codes, thus reducing the likelihood of errors in claims.
Those practices that deal with coding corrections for oncology cases may benefit from reviewing their processes for documentation, claims, and denials management.